Attached files
| file | filename |
|---|---|
| EXCEL - IDEA: XBRL DOCUMENT - ISTA PHARMACEUTICALS INC | Financial_Report.xls |
| 10-K - FORM 10-K - ISTA PHARMACEUTICALS INC | d275317d10k.htm |
| EX-32.2 - SECTION 906 CFO CERTIFICATION - ISTA PHARMACEUTICALS INC | d275317dex322.htm |
| EX-31.1 - SECTION 302 CEO CERTIFICATION - ISTA PHARMACEUTICALS INC | d275317dex311.htm |
| EX-32.1 - SECTION 906 CEO CERTIFICATION - ISTA PHARMACEUTICALS INC | d275317dex321.htm |
| EX-31.2 - SECTION 302 CFO CERTIFICATION - ISTA PHARMACEUTICALS INC | d275317dex312.htm |
| EX-10.12 - EXECUTIVE EMPLOYMENT AGREEMENT DATED NOVEMBER 30, 2011 - ISTA PHARMACEUTICALS INC | d275317dex1012.htm |
| EX-10.13 - FORM OF EXECUTIVE EMPLOYMENT AGREEMENT DATED DECEMBER 2, 2011 - ISTA PHARMACEUTICALS INC | d275317dex1013.htm |
| EX-10.13.1 - SCHEDULE OF PARTIES TO EXECUTIVE EMPLOYMENT AGREEMENT - ISTA PHARMACEUTICALS INC | d275317dex10131.htm |
Exhibit 23.1
Consent of Independent Registered Public Accounting Firm
We consent to the incorporation by reference in the following Registration Statements of ISTA Pharmaceuticals, Inc.:
| (1) | Registration Statement (Form S-3 No. 333-82726), |
| (2) | Registration Statement (Form S-3 No. 333-90994), |
| (3) | Registration Statement (Form S-3 No. 333-101120), |
| (4) | Registration Statement (Form S-3 No. 333-103820), |
| (5) | Registration Statement (Form S-3 No. 333-114815), |
| (6) | Registration Statement (Form S-3 No. 333-135799), |
| (7) | Registration Statement (Form S-3 No. 333-144344), |
| (8) | Registration Statement (Form S-3 No. 333-144345), |
| (9) | Registration Statement (Form S-3 No. 333-154713), |
| (10) | Registration Statement (Form S-3 No. 333-155187), |
| (11) | Registration Statement (Form S-3 No. 333-173936), |
| (12) | Registration Statements (Form S-8 Nos. 333-56042), |
| (13) | Registration Statements (Form S-8 No.333-103281), |
| (13) | Registration Statements (Form S-8 No 333-103276), |
| (14) | Registration Statements (Form S-8 No 333-103279), |
| (16) | Registration Statements (Form S-8 No 333-104434), |
| (17) | Registration Statements (Form S-8 No 333-119910), |
| (18) | Registration Statements (Form S-8 No 333-123026), |
| (19) | Registration Statements (Form S-8 No 333-129036), |
| (20) | Registration Statements (Form S-8 No 333-131793), |
| (21) | Registration Statements (Form S-8 No 333-138204), |
| (22) | Registration Statements (Form S-8 No 333-140577), |
| (23) | Registration Statements (Form S-8 No 333-149621), |
| (24) | Registration Statements (Form S-8 No 333-160348), |
| (25) | Registration Statements (Form S-8 No 333-164357), |
| (26) | Registration Statements (Form S-8 No 333-164358), |
of our reports dated February 27, 2012, related to the financial statements and financial statement schedule and the effectiveness of ISTA Pharmaceuticals, Inc.’s internal control over financial reporting, included in this Annual Report (Form 10-K) of ISTA Pharmaceuticals, Inc. for the year ended December 31, 2011.
| /S/ BDO USA LLP | ||
Costa Mesa, California
February 27, 2012